EWSR1 and Ewing sarcoma: Riggi has demonstrated that the fused transcription activator EWS-FLI1 vital oncogene is capable of transforming primary bone marrow-derived mesenchymal progenitor cells, leading to the formation of tumors that display all of the hallmarks of Ewing’s sarcoma [27].